Drugs / iHIVARNA-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02888756 | Apr 2017 → Feb 2018 | HIV infectious disease | Rob Gruters | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iHIVARNA-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02888756 ↗ |
| Route | Other | “Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal...” PMID 31208472 ↗ Jun 2019 |